These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 19614770)

  • 1. The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas.
    Capouillez A; Debauve G; Decaestecker C; Filleul O; Chevalier D; Mortuaire G; Coppée F; Leroy X; Belayew A; Saussez S
    Histopathology; 2009 Jul; 55(1):77-90. PubMed ID: 19614770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 upregulation during tumor progression in head and neck cancer.
    Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
    Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas.
    Capouillez A; Decaestecker C; Filleul O; Chevalier D; Coppée F; Leroy X; Belayew A; Saussez S
    Virchows Arch; 2008 Nov; 453(5):491-9. PubMed ID: 18825407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.
    Saussez S; Cucu DR; Decaestecker C; Chevalier D; Kaltner H; André S; Wacreniez A; Toubeau G; Camby I; Gabius HJ; Kiss R
    Ann Surg Oncol; 2006 Jul; 13(7):999-1009. PubMed ID: 16788763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
    Saussez S; Decaestecker C; Lorfevre F; Chevalier D; Mortuaire G; Kaltner H; André S; Toubeau G; Gabius HJ; Leroy X
    Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
    Sesterhenn AM; Mandic R; Dünne AA; Werner JA
    Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
    Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
    Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma.
    Marioni G; Ottaviano G; Marchese-Ragona R; Giacomelli L; Bertolin A; Zanon D; Marino F; Staffieri A
    Acta Otolaryngol; 2006 Feb; 126(2):197-203. PubMed ID: 16428200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas.
    Saussez S; Decaestecker C; Lorfevre F; Cucu DR; Mortuaire G; Chevalier D; Wacreniez A; Kaltner H; André S; Toubeau G; Camby I; Gabius HJ; Kiss R
    Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
    Luzar B; Poljak M; Fischinger J; Klopcic U; Gale N
    J Laryngol Otol; 2005 Nov; 119(11):917-21. PubMed ID: 16354348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7.
    Saussez S; Cludts S; Capouillez A; Mortuaire G; Smetana K; Kaltner H; André S; Leroy X; Gabius HJ; Decaestecker C
    Int J Oncol; 2009 Feb; 34(2):433-9. PubMed ID: 19148478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma.
    Uwa N; Kataoka TR; Torii I; Sato A; Nishigami T; Song M; Daimon T; Saeki N; Sagawa K; Mouri T; Terada T; Sakagami M; Tsujimura T
    Acta Otolaryngol; 2011 Mar; 131(3):323-9. PubMed ID: 21142741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic diagnosis of laryngeal and hypopharyngeal squamous cell carcinoma in sputum.
    Matsuda M; Nagumo S; Horai T; Yoshino K
    Acta Cytol; 1988; 32(5):655-7. PubMed ID: 3421013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of cyclooxygenase-2 expression in hypopharyngeal squamous cell carcinoma.
    Goto R; Hoshikawa H; Fujii T; Indo K; Yoshino K; Imaida K; Mori N
    Oncol Rep; 2008 Mar; 19(3):645-50. PubMed ID: 18288396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunohistochemical expression of p21WAF1/Cip1 and Proliferating cell nuclear antigen in laryngeal squamous cell carcinomas.
    Li X; Izumaru S; Sakamoto K; Miyajima Y; Nakashima T
    J Laryngol Otol; 2006 Dec; 120(12):1042-8. PubMed ID: 16995968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.